INVO Fertility, Inc.
Financial highlights
| Metric | FY 12/31/24 | FY 12/31/23 | FY 09/30/23 | FY 06/30/23 | FY 03/21/23 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $6.5M | $3.0M | — | — | — |
| Cost of revenue | $3.7M | $2.0M | — | — | — |
| Selling, general & administrative | $9.1M | $7.5M | — | — | — |
| Research and development | $489,660 | $165,945 | — | — | — |
| Operating expenses | $14.7M | $9.8M | — | — | — |
| Operating income | -$8.1M | -$6.8M | — | — | — |
| Interest expense | $1.1M | $925,909 | — | — | — |
| Pretax income | -$9.1M | -$8.0M | — | — | — |
| Income tax expense | -$22,913 | $27,786 | — | — | — |
| Net income | -$9.1M | -$8.0M | — | — | — |
| Balance Sheet | |||||
| Current assets | $1.3M | $1.3M | — | — | — |
| Total assets | $46.4M | $18.5M | $17.0M | $4.9M | $5.8M |
| Current liabilities | $17.9M | $8.0M | $4.7M | $4.3M | $4.4M |
| Total liabilities | $26.2M | $17.6M | $16.7M | $6.6M | $5.7M |
| Stockholders' equity | $12.7M | $892,825 | — | — | — |
| Cash Flow Statement | |||||
| Cash from operations | -$3.0M | -$4.8M | — | — | — |
| Depreciation and amortization | $919,603 | $200,894 | — | — | — |
| Capital expenditure | $183,703 | $444,722 | — | — | — |
| Free cash flow | -$3.2M | -$5.2M | — | — | — |
Shares outstanding 15.1M
Annual filing data through FY ended December 31, 2024; float as of July 4, 2026.